跳至主要内容
临床试验/NCT03632174
NCT03632174已完成不适用

Clinical Study for the Evaluation and Comparison of Cutaneous Acceptability and the Efficacy of 2 Cosmetic Products, Under Normal Conditions of Use, in Adult Participants With Atopic Dermatitis

BioGaia AB1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2019年1月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
BioGaia AB
入组人数
36
试验地点
1
主要终点
Appraisal of Cutaneous acceptability of the investigational products by dermatologist investigator

研究概览

简要总结

The study consists in the application of 2 investigational products (one group per investigational product) under normal conditions of use, in adult participants with Atopic Dermatitis.

It is carried out on cosmetic products, with the aim to further confirm safety of these products

详细描述

Probiotics are live micro-organisms which when administered in adequate amounts can exert a health benefit on the host. This health-promoting effects of Lactobacillus reuteri have been extensively studied in the gastrointestinal tract but it is clear that other areas are also interesting for the use of probiotics.

Atopic Dermatitis is a relapsing inflammatory skin disease appearing on persons with a genetic predisposition of allergic pathology. AD generally starts in childhood, however in some cases can continue into adult hood, in at least 10% of cases. AD can effect a persons quality of life and in the chronic stage it can present with dry skin and lichenification.

Research has shown that probiotics have an antimicrobial, anti-inflammatory and barrier function effect, and could therefore be used on subjects with Atopic Dermatitis to relieve and protect.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant has not been on a course of long term treatment in particular with aspirin, products containing aspirin, anti-inflammatories, antibiotics, antihistamines, corticoids
  • Participant presenting with mild to moderate atopic dermatitis according to the definition of the UK Working Party's Diagnostic Criteria for Atopic Dermatitis (SCORAD index >25)
  • Participant presenting with a current lesion of Atopic Dermatitis on defined area

排除标准

  • Participant is pregnant, breast feeding or not willing to take the necessary precautions to avoid pregnancy during the study
  • Participant having background of intolerance or allergy
  • Participant not respecting the washout period during which a person may not be involved in any other biomedical research projects
  • Participant having skin exposed to sunlight within 2 weeks preceding the inclusion
  • Participant having modified his/her cosmetic habits during the last two weeks

结局指标

主要结局

Appraisal of Cutaneous acceptability of the investigational products by dermatologist investigator

时间窗: 4 weeks

Cutaneous acceptability is assessed on the basis of clinical examination of the skin for physical signs (erythema, oedema, dryness) linked to the use of the investigational product and also evaluation the functional signs (prickling, tightness, heating)

次要结局

  • Change in Local SCORAD index(baseline, at 4, and 8 weeks)
  • Change in SCORAD index over 8 week period(baseline, at 4 and 8 weeks)

研究者

发起方
BioGaia AB
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验